Work

Sunitinib (SU) response in imatinib-resistant (IM-R) GIST correlates with KIT and PDGFRA mutation status

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.9502

Authors: M. C. Heinrich, R. G. Maki, C. L. Corless, C. R. Antonescu, J. A. Fletcher, C. D. Fletcher, X. Huang, C. M. Baum, G. D. Demetri

Institutions: Brigham and Women's Hospital, Memorial Sloan Kettering Cancer Center, Pfizer (United States), Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center

Language: English

Topic: Gastrointestinal Tumor Research and Treatment

Subfield: Gastroenterology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2252961166

Cites:

Cited by: 84

Related to: 10